|
MED26 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.382400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.786220E-01 |
| Normal-vs-Stage2 |
1.517990E-01 |
| Normal-vs-Stage3 |
4.499800E-02 |
| Normal-vs-Stage4 |
3.085200E-01 |
| Stage1-vs-Stage2 |
4.620200E-01 |
| Stage1-vs-Stage3 |
2.746000E-01 |
| Stage1-vs-Stage4 |
7.976000E-01 |
| Stage2-vs-Stage3 |
9.474000E-01 |
| Stage2-vs-Stage4 |
6.807600E-01 |
| Stage3-vs-Stage4 |
6.365200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.333700E-02 |
| Normal-vs-AfricanAmerican |
8.786000E-01 |
| Normal-vs-Asian |
6.114000E-01 |
| Caucasian-vs-AfricanAmerican |
4.192000E-01 |
| Caucasian-vs-Asian |
4.283200E-01 |
| AfricanAmerican-vs-Asian |
8.465400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.147000E-01 |
| Normal-vs-Female |
1.210100E-02 |
| Male-vs-Female |
1.148120E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.857570E-01 |
| Normal-vs-Age(41-60Yrs) |
5.398200E-02 |
| Normal-vs-Age(61-80Yrs) |
9.754200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.638800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.002000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.154600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.404000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.176800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.833600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.558400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.140230E-03 |
| Classical-VS-Follicular |
1.299590E-01 |
| Classical-VS-Other |
6.679200E-01 |
| Classical-VS-Normal |
4.738200E-01 |
| Tall-VS-Follicular |
5.775900E-02 |
| Tall-VS-Other |
2.196200E-02 |
| Tall-VS-Normal |
1.208850E-04 |
| Follicular-VS-Other |
4.255400E-01 |
| Follicular-VS-Normal |
7.306200E-02 |
| Other-VS-Normal |
8.178200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.463500E-02 |
| Normal-vs-N1 |
1.637790E-01 |
| N0-vs-N1 |
9.345800E-01 |
|
|
